Please login to the form below
Sensyne Health
This page shows the latest Sensyne Health news and features for those working in and with pharma, biotech and healthcare.
Bayer taps Sensyne Health AI and real world data for cardiovascular research
Sensyne Health says the deal will generate revenues of £5mn over two years, and its partner NHS trusts will receive a 4% share of revenues from the collaboration. ... priority for the NHS, using Sensyne Health’s proprietary clinical AI technology
Latest news
-
Digital division NHSX looks to improve experience for doctors as well as patients
Patient and public buy-in for data use essential. Health minister Nicola Blackwood has laid out priorities for the NHS’ new ‘NHSX’ division – and making digital technology easier to use for ... There have been numerous concerns about how
-
UK biotech booms in 2018, despite Brexit worries
2018’s UK IPOs came fromSensyne Health, Acacia Pharma and Renalytix AI.
-
Avenir acquires Cherry, EY wins new account and GK unites businesses
and Canada.”. EY wins new account. Sensyne Health, a clinical AI tech focused company, has appointed professional services firm EY to design and build specialist resources. ... Pamela Spence, Partner and EY Global Health Sciences and Wellness Leader,
-
Artificial intelligence in healthcare
Investments like these are helping to drive explosive growth in the health AI sector. ... Just a few weeks ago, for example, UK-based Sensyne Health made its debut on the AIM, raising £60m to advance a business model based on sifting through anonymised
-
AI company Sensyne raises £60m in IPO
University of Oxford-developed tech powers health-focused company. Sensyne is led by Powderject founder and ex-minister Lord Drayson. ... Artificial intelligence company Sensyne Health has successfully made its debut on London’s AIM exchange, raising
More from news
Approximately 2 fully matching, plus 4 partially matching documents found.
Latest Intelligence
-
AI: powering healthcare, empowering patients Physician perceptions of AI and the future of pharma
In the face of the coronavirus, innovative technologies such as artificial intelligence (AI) and machine learning (ML) have proven vital for the protection and promotion of public health. ... For example, Roche recently signed an agreement with British
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
- Account Manager, Healthcare Marketing Creative Agency, Fixed ter...
- Highly competitive salary
- Home Based Account Manager, Medical Communications, UK, Pharma/M...
- Highly competitive salary
- Account Manager, 6 month contract, Healthcare Brand communicatio...
- Highly competitive salary
- Account Director, Healthcare Marketing Creative Agency, Fixed te...
- Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
- Highly competitive salary
- Senior Medical Copywriter - Highly Awarded Advertising Agency
- £50,000 - £60,000 yearly
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
- BMS and Janssen’s antithrombotic granted FDA fast track designation
- Pfizer’s antibiotic combination shows promise in treating multi-drug resistant infections
- Sanofi's frexalimab shows promise in relapsing forms of MS
- EMA recommends revoking marketing authorisation for Novartis’ sickle cell disease drug
- Pfizer’s RSV vaccine approved by FDA for older adults
- Navigating patients step by step on their clinical trial journey
- Innovative Trials responds to national recommendations to tackle UK clinical trial decline
- AstraZeneca shares positive phase 3 results for Tagrisso in lung cancer
- BMS presents positive four-year results for Opdivo combination in lung cancer
- Tuberculosis – why it remains a major global public health challenge
- Whitepaper: Closing the gap with compelling healthcare communications
No results were found
PMHub
OPEN Health
OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health...
Latest intelligence
- Tuberculosis – why it remains a major global public health challenge
- Innovative collaboration is required to address the major public health challenges around TB and expedite drug development...
- Whitepaper: Closing the gap with compelling healthcare communications
- Want to learn how to close the distance between a person’s current health and their healthiest possible self?...
- Healing the Healers
- Because if we do not heal the healers, who is going to heal us?...
